A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

Clinical trial NCT07055477 · RECRUITING

Trial details

NCT number: NCT07055477
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed and/or Refractory Mature T Cell Malignancy Peripheral T-Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Anaplastic Large Cell Lymphoma Hepatosplenic T-cell Lymphoma Monomorphic Epithelialtropic Intestinal Lymphoma Enteropathy Associated T-cell Lymphoma Cutaneous T-Cell Lymphoma Mycosis Fungoides Subacute Panniculitis-like T-cell Lymphoma

Start date: 2025-09-29
Primary completion: 2044-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.